Identification of a candidate therapeutic autophagy-inducing peptide

Sanae Shoji-Kawata, Rhea Sumpter, Matthew Leveno, Grant R. Campbell, Zhongju Zou, Lisa Kinch, Angela D. Wilkins, Qihua Sun, Kathrin Pallauf, Donna MacDuff, Carlos Huerta, Herbert W. Virgin, J. Bernd Helms, Ruud Eerland, Sharon A. Tooze, Ramnik Xavier, Deborah J. Lenschow, Ai Yamamoto, David King, Olivier LichtargeNick V. Grishin, Stephen A. Spector, Dora V. Kaloyanova, Beth Levine

Research output: Contribution to journalArticle

372 Citations (Scopus)

Abstract

The lysosomal degradation pathway of autophagy has a crucial role in defence against infection, neurodegenerative disorders, cancer and ageing. Accordingly, agents that induce autophagy may have broad therapeutic applications. One approach to developing such agents is to exploit autophagy manipulation strategies used by microbial virulence factors. Here we show that a peptide, Tat-beclin 1-derived from a region of the autophagy protein, beclin 1, which binds human immunodeficiency virus (HIV)-1 Nef-is a potent inducer of autophagy, and interacts with a newly identified negative regulator of autophagy, GAPR-1 (also called GLIPR2). Tat-beclin 1 decreases the accumulation of polyglutamine expansion protein aggregates and the replication of several pathogens (including HIV-1) in vitro, and reduces mortality in mice infected with chikungunya or West Nile virus. Thus, through the characterization of a domain of beclin 1 that interacts with HIV-1 Nef, we have developed an autophagy-inducing peptide that has potential efficacy in the treatment of human diseases.

Original languageEnglish (US)
Pages (from-to)201-206
Number of pages6
JournalNature
Volume494
Issue number7436
DOIs
StatePublished - Feb 14 2013

Fingerprint

Autophagy
Peptides
HIV-1
Therapeutics
West Nile virus
Virulence Factors
Neurodegenerative Diseases
Mortality
Beclin-1
Infection
Neoplasms

ASJC Scopus subject areas

  • General

Cite this

Shoji-Kawata, S., Sumpter, R., Leveno, M., Campbell, G. R., Zou, Z., Kinch, L., ... Levine, B. (2013). Identification of a candidate therapeutic autophagy-inducing peptide. Nature, 494(7436), 201-206. https://doi.org/10.1038/nature11866

Identification of a candidate therapeutic autophagy-inducing peptide. / Shoji-Kawata, Sanae; Sumpter, Rhea; Leveno, Matthew; Campbell, Grant R.; Zou, Zhongju; Kinch, Lisa; Wilkins, Angela D.; Sun, Qihua; Pallauf, Kathrin; MacDuff, Donna; Huerta, Carlos; Virgin, Herbert W.; Bernd Helms, J.; Eerland, Ruud; Tooze, Sharon A.; Xavier, Ramnik; Lenschow, Deborah J.; Yamamoto, Ai; King, David; Lichtarge, Olivier; Grishin, Nick V.; Spector, Stephen A.; Kaloyanova, Dora V.; Levine, Beth.

In: Nature, Vol. 494, No. 7436, 14.02.2013, p. 201-206.

Research output: Contribution to journalArticle

Shoji-Kawata, S, Sumpter, R, Leveno, M, Campbell, GR, Zou, Z, Kinch, L, Wilkins, AD, Sun, Q, Pallauf, K, MacDuff, D, Huerta, C, Virgin, HW, Bernd Helms, J, Eerland, R, Tooze, SA, Xavier, R, Lenschow, DJ, Yamamoto, A, King, D, Lichtarge, O, Grishin, NV, Spector, SA, Kaloyanova, DV & Levine, B 2013, 'Identification of a candidate therapeutic autophagy-inducing peptide', Nature, vol. 494, no. 7436, pp. 201-206. https://doi.org/10.1038/nature11866
Shoji-Kawata S, Sumpter R, Leveno M, Campbell GR, Zou Z, Kinch L et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature. 2013 Feb 14;494(7436):201-206. https://doi.org/10.1038/nature11866
Shoji-Kawata, Sanae ; Sumpter, Rhea ; Leveno, Matthew ; Campbell, Grant R. ; Zou, Zhongju ; Kinch, Lisa ; Wilkins, Angela D. ; Sun, Qihua ; Pallauf, Kathrin ; MacDuff, Donna ; Huerta, Carlos ; Virgin, Herbert W. ; Bernd Helms, J. ; Eerland, Ruud ; Tooze, Sharon A. ; Xavier, Ramnik ; Lenschow, Deborah J. ; Yamamoto, Ai ; King, David ; Lichtarge, Olivier ; Grishin, Nick V. ; Spector, Stephen A. ; Kaloyanova, Dora V. ; Levine, Beth. / Identification of a candidate therapeutic autophagy-inducing peptide. In: Nature. 2013 ; Vol. 494, No. 7436. pp. 201-206.
@article{ef62aa83e7184d05b908bfee12dd445f,
title = "Identification of a candidate therapeutic autophagy-inducing peptide",
abstract = "The lysosomal degradation pathway of autophagy has a crucial role in defence against infection, neurodegenerative disorders, cancer and ageing. Accordingly, agents that induce autophagy may have broad therapeutic applications. One approach to developing such agents is to exploit autophagy manipulation strategies used by microbial virulence factors. Here we show that a peptide, Tat-beclin 1-derived from a region of the autophagy protein, beclin 1, which binds human immunodeficiency virus (HIV)-1 Nef-is a potent inducer of autophagy, and interacts with a newly identified negative regulator of autophagy, GAPR-1 (also called GLIPR2). Tat-beclin 1 decreases the accumulation of polyglutamine expansion protein aggregates and the replication of several pathogens (including HIV-1) in vitro, and reduces mortality in mice infected with chikungunya or West Nile virus. Thus, through the characterization of a domain of beclin 1 that interacts with HIV-1 Nef, we have developed an autophagy-inducing peptide that has potential efficacy in the treatment of human diseases.",
author = "Sanae Shoji-Kawata and Rhea Sumpter and Matthew Leveno and Campbell, {Grant R.} and Zhongju Zou and Lisa Kinch and Wilkins, {Angela D.} and Qihua Sun and Kathrin Pallauf and Donna MacDuff and Carlos Huerta and Virgin, {Herbert W.} and {Bernd Helms}, J. and Ruud Eerland and Tooze, {Sharon A.} and Ramnik Xavier and Lenschow, {Deborah J.} and Ai Yamamoto and David King and Olivier Lichtarge and Grishin, {Nick V.} and Spector, {Stephen A.} and Kaloyanova, {Dora V.} and Beth Levine",
year = "2013",
month = "2",
day = "14",
doi = "10.1038/nature11866",
language = "English (US)",
volume = "494",
pages = "201--206",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7436",

}

TY - JOUR

T1 - Identification of a candidate therapeutic autophagy-inducing peptide

AU - Shoji-Kawata, Sanae

AU - Sumpter, Rhea

AU - Leveno, Matthew

AU - Campbell, Grant R.

AU - Zou, Zhongju

AU - Kinch, Lisa

AU - Wilkins, Angela D.

AU - Sun, Qihua

AU - Pallauf, Kathrin

AU - MacDuff, Donna

AU - Huerta, Carlos

AU - Virgin, Herbert W.

AU - Bernd Helms, J.

AU - Eerland, Ruud

AU - Tooze, Sharon A.

AU - Xavier, Ramnik

AU - Lenschow, Deborah J.

AU - Yamamoto, Ai

AU - King, David

AU - Lichtarge, Olivier

AU - Grishin, Nick V.

AU - Spector, Stephen A.

AU - Kaloyanova, Dora V.

AU - Levine, Beth

PY - 2013/2/14

Y1 - 2013/2/14

N2 - The lysosomal degradation pathway of autophagy has a crucial role in defence against infection, neurodegenerative disorders, cancer and ageing. Accordingly, agents that induce autophagy may have broad therapeutic applications. One approach to developing such agents is to exploit autophagy manipulation strategies used by microbial virulence factors. Here we show that a peptide, Tat-beclin 1-derived from a region of the autophagy protein, beclin 1, which binds human immunodeficiency virus (HIV)-1 Nef-is a potent inducer of autophagy, and interacts with a newly identified negative regulator of autophagy, GAPR-1 (also called GLIPR2). Tat-beclin 1 decreases the accumulation of polyglutamine expansion protein aggregates and the replication of several pathogens (including HIV-1) in vitro, and reduces mortality in mice infected with chikungunya or West Nile virus. Thus, through the characterization of a domain of beclin 1 that interacts with HIV-1 Nef, we have developed an autophagy-inducing peptide that has potential efficacy in the treatment of human diseases.

AB - The lysosomal degradation pathway of autophagy has a crucial role in defence against infection, neurodegenerative disorders, cancer and ageing. Accordingly, agents that induce autophagy may have broad therapeutic applications. One approach to developing such agents is to exploit autophagy manipulation strategies used by microbial virulence factors. Here we show that a peptide, Tat-beclin 1-derived from a region of the autophagy protein, beclin 1, which binds human immunodeficiency virus (HIV)-1 Nef-is a potent inducer of autophagy, and interacts with a newly identified negative regulator of autophagy, GAPR-1 (also called GLIPR2). Tat-beclin 1 decreases the accumulation of polyglutamine expansion protein aggregates and the replication of several pathogens (including HIV-1) in vitro, and reduces mortality in mice infected with chikungunya or West Nile virus. Thus, through the characterization of a domain of beclin 1 that interacts with HIV-1 Nef, we have developed an autophagy-inducing peptide that has potential efficacy in the treatment of human diseases.

UR - http://www.scopus.com/inward/record.url?scp=84873709314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873709314&partnerID=8YFLogxK

U2 - 10.1038/nature11866

DO - 10.1038/nature11866

M3 - Article

C2 - 23364696

AN - SCOPUS:84873709314

VL - 494

SP - 201

EP - 206

JO - Nature

JF - Nature

SN - 0028-0836

IS - 7436

ER -